# Lornoxicam Versus Etodolac After Third Molar Surgery

> **NCT05679453** · PHASE4 · COMPLETED · sponsor: **Kutahya Health Sciences University** · enrollment: 20 (actual)

## Conditions studied

- Pain, Acute
- Edema
- Trismus

## Interventions

- **DRUG:** Lornoxicam 8 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT05679453
- **Lead sponsor:** Kutahya Health Sciences University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-20
- **Primary completion:** 2022-09-25
- **Final completion:** 2022-09-29
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05679453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05679453, "Lornoxicam Versus Etodolac After Third Molar Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05679453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*